< Back to Press

ASCENSIA DIABETES CARE TO ATTEND 9TH INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES & TREATMENTS FOR DIABETES, THEIR FIRST CONGRESS SINCE COMPANY LAUNCH

Basel, Switzerland

Ascensia Diabetes Care today announced that they will be attending the 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) later this week. The ATTD 2016 has been chosen as the first global conference where Ascensia Diabetes Care will be present since the close of the sale of the Diabetes Care business from Bayer AG to Panasonic Healthcare Holdings Co., Ltd., which was announced on 5 January 2016. The ATTD is taking place on 3-6 February 2016 in Milan, Italy. 

Ascensia Diabetes Care has chosen this conference as the first opportunity to present the new stand-alone company to the clinical community and showcase its dedication and commitment to the care of people with diabetes. It will use the ATTD to present their high quality solutions and tools, including the world renowned CONTOUR^® portfolio of blood glucose monitoring systems. Ascensia Diabetes Care will be present at Booth 10 in the Exhibition Area.

"We are very excited to be attending our first global diabetes conference as Ascensia Diabetes Care and are looking forward to presenting our new company to clinicians and researchers from around the world," said Michael Kloss, Global CEO of Ascensia Diabetes Care. "As Ascensia Diabetes Care we will build on our legacy in this market and continue to be a trustworthy provider of reliable, high-performance solutions that could make a positive, daily difference for people with diabetes."

"The ATTD conference provides the perfect opportunity to showcase our current products and future development programme. The data that we are presenting demonstrates that we are at the forefront of innovation in diabetes care and will show how we will be introducing new technologies that may enhance the lives of patients living with diabetes," added Michael Kloss.

Ascensia Diabetes Care will be presenting key findings from research into innovative diabetes care solutions for patients. Posters and presentations will highlight compelling data from blood glucose monitoring systems, both launched and in development, including a wireless-enabled blood glucose meter that links to a smart mobile device via Bluetooth^® technology.

Accuracy and User Performance Evaluation of a New, Wireless-Enabled, Blood Glucose Meter in Development that Links to a Smart Mobile Device Via Bluetooth Connectivity (T. Bailey et al., E-POSTER DISCUSSION SESSION 6, Exhibition Area, February 5, 2016, 10:15 - 10:20)

A New, Wireless-Enabled, Blood Glucose Meter in Development that Links to a Smart Mobile Device Via Bluetooth Connectivity: Accuracy and User Performance Evaluation (M. Christiansen et al., E-POSTER EP07, Exhibition Area, available from February 3, 2016)

Performance Evaluation of Three Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel (D. Rittmeyer et al. E-POSTER EP07, Exhibition Area, available from February 3, 2016)

Notes for Editors

About Ascensia Diabetes Care

Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping improve the lives of people with diabetes by empowering them to take charge of their health. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a simple, positive, daily difference for people with diabetes.

Home to the world renowned CONTOUR^TM portfolio, our products combine advanced technology with user-friendly functionality that helps people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products. As a leader in diabetes care and a trusted partner, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy and compliance.

Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Following the close of the transaction in all countries, Ascensia Diabetes Care will have more than 1,400 employees and operations in 38 countries.

For further information please visit the Ascensia Diabetes Care website at: http://www.ascensia.com

Contact

For further information please contact:
Joseph Delahunty
VP, Global Head of Communications
Ascensia Diabetes Care
E-mail: joseph.delahunty@ascensia.com
Phone: +41 61 560 8760